Avascular Necrosis of the Talus
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
P2
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
Paragon 28Patient Specific Talus Spacer
Clinical Trials (1)
Patient Specific Talus Spacer Post Approval Study
Start: Jul 2022Est. completion: Nov 2029
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
1 companies competing in this space